Patient Pathfinder: Clinical Trials
Clinical Trials for Melanoma
Every life-saving or life-extending treatment that's available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it's approved by the U.S. Food and Drug Administration.
There are 454 active Melanoma trials
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
MElanoma Research Lymph Node Prediction Implementation National_001
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
War on Melanoma™ Public Health & Education Campaign
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
There are 454 active Melanoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.